Tricaprilin in Mild to Moderate Alzheimer's Disease

Inclusion Criteria: * Informed Consent Form signed by patient and caregiver * Diagnosis of probably Alzheimer's disease of mild to moderate severity * Age 50 or older * If female, 2 years postmenopausal or surgically sterile * Hearing, vision, and physical abilities adequate to perform assessments (corrective aids allowed) * Caregiver to attend all visits, perform assessments, and supervise administration of study medication * CT or MRI within 24 months prior to screening compatible with a diagnosis of probably Alzheimer's disease * Modified Hachinski Ischemia Scale score of 4 or less * ADAS-Cog score between 15 and 35 inclusive at screening * MMSE score between 14 and 24 inclusive at screening * Stable medical condition for 3 consecutive months immediately prior to baseline * No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Exclusion Criteria: * Any condition that would, in the opinion of the Principal Investigator, render the patient or the caregiver unsuitable for the study, or place them at substantial risk of adverse outcome * Unwillingness or inability of the patient and/or caregiver to fulfill the requirements of the study * Resident in a skilled nursing facility * Any significant neurological disease other than probable AD (e.g. Parkinson's disease, Huntington's disease, brain tumor, normal pressure hydrocephalus, progressive supranuclear palsy, seizure disorder, subdural hemat…